Knights Of Columbus Asset Advisors LLC Castle Biosciences Inc Transaction History
Knights Of Columbus Asset Advisors LLC
- $1.35 Billion
- Q1 2024
A detailed history of Knights Of Columbus Asset Advisors LLC transactions in Castle Biosciences Inc stock. As of the latest transaction made, Knights Of Columbus Asset Advisors LLC holds 25,133 shares of CSTL stock, worth $547,145. This represents 0.04% of its overall portfolio holdings.
Number of Shares
25,133
Previous 106,262
76.35%
Holding current value
$547,145
Previous $2.29 Million
75.75%
% of portfolio
0.04%
Previous 0.15%
Shares
15 transactions
Others Institutions Holding CSTL
# of Institutions
162Shares Held
25.3MCall Options Held
82.2KPut Options Held
150K-
Black Rock Inc. New York, NY2.6MShares$56.5 Million0.0% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT2.55MShares$55.5 Million0.3% of portfolio
-
Granahan Investment Management, LLC Waltham, MA1.63MShares$35.4 Million1.3% of portfolio
-
Principal Financial Group Inc Des Moines, IA1.53MShares$33.4 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.49MShares$32.5 Million0.0% of portfolio
About CASTLE BIOSCIENCES INC
- Ticker CSTL
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 26,297,000
- Market Cap $572M
- Description
- Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...